Professor Emeritus Dr. Lindon Eaves, D.Sc. presents an insightful seminar at the Principles of Human Behavioral Genetics class on February 29, 2016 at the Virginia Institute for Psychiatric and Behavioral Genetics.
Continue reading →
Vladimir Vladimirov, M.D., Ph.D., was awarded a two-year grant from the National Institute of Alcohol Abuse and Alcoholism in the amount of $419,375 to study the genome-wide expression patterns of genes and miRNA in the nucleus accumbens and prefrontal cortex from subjects with alcohol dependence (AD) and healthy controls. The award has two main goals: i) identify AD-relevant gene and miRNA networks and ii) detect genetic polymorphisms found to be associated with AD ...
Continue reading →
Michael Neale, Ph.D. is Professor of Psychiatry, Human and Molecular Genetics, and Psychology, as well as associate director of the Virginia Institute for Psychiatric and Behavioral Genetics. His career in the field of psychiatric genetics started as an interest in psychology and neuroscience, which developed during his formative adolescent years after reading Jeffrey Gray’s The Psychology of Fear and Stress. Subsequently, he earned both his Bachelor’s and PhD degrees in psychology at the ...
Continue reading →
In the largest and most comprehensive study of its kind, researchers have successfully identified two novel genetic variants that could increase risk for the five primary anxiety disorders. The findings are the result of an international collaboration among 34 researchers from Virginia Commonwealth University and throughout academic institutions in the United States, Europe and Australia.
The international research team looked at genetic risk factors that are common across the five primary anxiety disorders identified in the fifth edition of the Diagnostic ...
Continue reading →
A Virginia Institute for Psychiatric and Behavioral Genetics site review presentation presented by Brien Riley, Ph.D.
Continue reading →
A Virginia Institute for Psychiatric and Behavioral Genetics site review presentation presented by Michael Neale, Ph.D. and Silviu-Alin Bacanu, Ph.D.
Continue reading →
The National Institutes of Health awarded a $5 million grant to Virginia Commonwealth University to take part in a landmark study on substance use and adolescent brain development. NIH’s Adolescent Brain Cognitive Development study is the largest longitudinal neuroimaging study of human brain development ever launched.
The five-year grant will fund research that aims to map the neuropsychological trajectories of the developing brain. The study holds the potential to expand on current understandings of both normal and atypical brain development across ...
Continue reading →
Alexis Edwards, Ph.D. is Assistant Professor in the Department of Psychiatry. She has always been interested in behavior and completed her Ph.D. in Genetics, working with model systems of aggression. However, she then realized she could translate her work to human behavior. Therefore, her professional and personal passion for understanding the genetic and environmental influences on psychiatric illness led her to pursue her postdoctoral training at the Virginia Institute for ...
Continue reading →
Lindon Eaves, D.Sc. is one of the founders of the Virginia Institute for Psychiatric and Behavioral Genetics. He is currently professor emeritus at the Institute and has played a significant part in the development and application of a variety of research designs. These include the extended kin-ships of twins and longitudinal studies of twins and their parents. He has also developed some of the first methods for the structural analysis of multivariate genetic data ...
Continue reading →
An international team of researchers has identified more than 100 locations in the human genome associated with the risk of an individual developing schizophrenia, according to a study published online in the journal Nature this week.
The findings advance the knowledge of schizophrenia on the molecular level, and provide critical information about the biological pathways underlying the illness — which has been poorly understood until now.
By understanding the molecular and cellular pathways involved in schizophrenia, researchers may be able to develop ...
Continue reading →